These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24582564)

  • 1. Tumor endothelial expression of P-glycoprotein upon microvesicular transfer of TrpC5 derived from adriamycin-resistant breast cancer cells.
    Dong Y; Pan Q; Jiang L; Chen Z; Zhang F; Liu Y; Xing H; Shi M; Li J; Li X; Zhu Y; Chen Y; Bruce IC; Jin J; Ma X
    Biochem Biophys Res Commun; 2014 Mar; 446(1):85-90. PubMed ID: 24582564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells.
    Ma X; Cai Y; He D; Zou C; Zhang P; Lo CY; Xu Z; Chan FL; Yu S; Chen Y; Zhu R; Lei J; Jin J; Yao X
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16282-7. PubMed ID: 22988121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance.
    Ma X; Chen Z; Hua D; He D; Wang L; Zhang P; Wang J; Cai Y; Gao C; Zhang X; Zhang F; Wang T; Hong T; Jin L; Qi X; Chen S; Gu X; Yang D; Pan Q; Zhu Y; Chen Y; Chen D; Jiang L; Han X; Zhang Y; Jin J; Yao X
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6389-94. PubMed ID: 24733904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X; Chang Z; Song J; Gao G; Shen Z
    Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway.
    Zhang P; Liu X; Li H; Chen Z; Yao X; Jin J; Ma X
    Sci Rep; 2017 Jun; 7(1):3158. PubMed ID: 28600513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
    Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A methylation-based regulatory network for microRNA 320a in chemoresistant breast cancer.
    He DX; Gu XT; Jiang L; Jin J; Ma X
    Mol Pharmacol; 2014 Nov; 86(5):536-47. PubMed ID: 25159093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
    J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
    Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
    Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of vascular endothelial growth factor release in long-term drug-treated breast cancer via transient receptor potential channel 5-Ca(2+)-hypoxia-inducible factor 1α pathway.
    Zhu Y; Pan Q; Meng H; Jiang Y; Mao A; Wang T; Hua D; Yao X; Jin J; Ma X
    Pharmacol Res; 2015 Mar; 93():36-42. PubMed ID: 25579062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells.
    Tran TP; Kim HG; Choi JH; Na MK; Jeong HG
    Phytomedicine; 2013 May; 20(7):622-31. PubMed ID: 23466342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance.
    Zhang FF; Zhu YF; Zhao QN; Yang DT; Dong YP; Jiang L; Xing WX; Li XY; Xing H; Shi M; Chen Y; Bruce IC; Jin J; Ma X
    Eur J Pharmacol; 2014 Sep; 738():83-90. PubMed ID: 24877693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
    Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
    Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.
    Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC
    Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
    Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
    Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial localization of P-glycoprotein in the human breast cancer cell line MCF-7/ADM and its functional characterization.
    Shen Y; Chu Y; Yang Y; Wang Z
    Oncol Rep; 2012 May; 27(5):1535-40. PubMed ID: 22307172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
    Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
    Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil.
    Zhang L; Yang Y; Wei XY; Shi YR; Liu HY; Niu RF; Hao XS
    J Exp Clin Cancer Res; 2007 Jun; 26(2):201-7. PubMed ID: 17725099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Treatment with Gadopentetic Acid or Gadodiamide Increases TRPC5 Expression and Decreases Adriamycin Nuclear Accumulation in Breast Cancer Cells.
    Zhang W; Wang M; Lv W; White FA; Chen X; Obukhov AG
    Cells; 2023 May; 12(9):. PubMed ID: 37174704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.